A detailed history of Dundas Partners LLP transactions in Alcon Inc stock. As of the latest transaction made, Dundas Partners LLP holds 425,938 shares of ALC stock, worth $36.8 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares
425,938
Previous 425,938 -0.0%
Holding current value
$36.8 Million
Previous $38 Million 12.1%
% of portfolio
3.09%
Previous 2.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$77.58 - $92.26 $257,022 - $305,657
3,313 Added 0.78%
425,938 $38 Million
Q4 2023

Feb 08, 2024

BUY
$69.57 - $78.12 $1.49 Million - $1.67 Million
21,371 Added 5.33%
422,625 $33 Million
Q3 2023

Nov 14, 2023

BUY
$76.74 - $85.2 $1.27 Million - $1.41 Million
16,537 Added 4.3%
401,254 $31.1 Million
Q2 2023

Aug 10, 2023

BUY
$69.16 - $82.11 $26.6 Million - $31.6 Million
384,717 New
384,717 $31.9 Million

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $42.3B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Dundas Partners LLP Portfolio

Follow Dundas Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dundas Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Dundas Partners LLP with notifications on news.